Athmeya works at the intersection of political theory and applied ethics, particularly on how we can make democratic and just decisions on emerging technologies. He has a Ph.D. in political theory from UC Berkeley and an M.A. in bioethics from New York University.
Prior to the GLIDE fellowship, he was a postdoctoral scholar at the Institute for Practical Ethics at UC San Diego, where he worked with scientists developing "gene drive" mosquitoes, focusing on the fairness and legitimacy of decisions to deploy biotechnology in LMICs.
Chelsea is currently a clinical fellow in the Division of Infectious Diseases at Johns Hopkins University School of Medicine. She earned her medical degree from the Geisel School of Medicine at Dartmouth and completed residency in Internal Medicine at Emory University where she graduated with distinctions in Global Health and Leadership in Teaching and Education. In residency, her research focused on the ethical considerations of short-term global health experiences for medical trainees and developing research capacity in resource-limited settings.
She is interested generally in the intersection of global health ethics and infectious diseases with a particular focus on distributive justice around advancing infectious diseases diagnostics and therapeutics including global SARS-CoV-2 vaccination efforts.
Chelsea said ‘We are incredibly excited to be a part of the GLIDE collaborative and have the opportunity to work with ethics and infectious disease mentors from around the world.’
Jeff Kahn, Director of the Berman Institute, and Mike Parker, Director of the Wellcome Centre for Ethics and Humanities, welcomed the new Fellows: 'We are delighted that Chelsea and Athmeya are joining the GLIDE project to further the collaboration between our institutions and develop our programme of research on emerging and pressing issues in global infectious disease ethics.'